---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-007775"
form_type: "8-K"
ticker: "CDXS"
cik: "0001200375"
company_name: "CODEXIS, INC."
filed_at: "2025-01-16T23:59:59+00:00"
generated_at: "2026-05-27T23:45:57.211642+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Codexis appoints Christos Richards to Board of Directors

## Summary
- Appointment effective January 14, 2025 as Class II director with term until 2027 annual meeting.
- Richards is independent under Nasdaq rules; will serve on Nominating and Governance and Strategy Committees.
- Annual cash retainer of $50,000 plus $10,000 each for committee service; initial RSU grant of $200,000 vesting over three years.
- Richards brings executive search and biopharma board experience, previously on Coherus BioSciences board.
- No arrangements or transactions with the company other than standard director compensation.

## SEC filing metadata
- accession: 0001193125-25-007775
- form_type: 8-K
- ticker: CDXS
- cik: 0001200375
- company_name: CODEXIS, INC.
- filed_at: 2025-01-16T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1200375/000119312525007775/0001193125-25-007775-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1200375/000119312525007775/d876172d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-007775
- JSON: https://secwatch.observer/filing/0001193125-25-007775.json
- Plain text: https://secwatch.observer/filing/0001193125-25-007775.txt

## Key facts
- Executive change
  Christos Richards was appointed as Director at CODEXIS, INC..
  - Action: appointed
  - Role: Director
  source text: On January 14, 2025, the Board of Directors (the “Board”) of Codexis, Inc. (the “Company”), upon the recommendation of the Board’s Nominating and Corporate Governance Committee (the “Nominating and Corporate Governance Committee”), appointed Christos Richards as a member of the Board as a Class II director, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1200375/000119312525007775/0001193125-25-007775-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.